ON-demand Webcast

Implementation of a Weight of Evidence Carcinogenicity Assessment Aligned with ICH S1B

Enter your details below to watch the webcast.

First Name *

Last Name *

Job Title *

Company *

Email *

Country *

Opt-in to receive periodic industry insights, event invitations, product updates, and other information from Instem.

Comments

This webcast is part of the In Silico Insights session series provided by Instem

This presentation reviews the state-of-the-art in assessing carcinogenicity based on the ICH S1B weight of evidence (WoE) addendum, including progress towards developing a transparent and defendable protocol based on the 6 WoE factors.

Dr. Glenn Myatt

SVP of In Silico & Translational Science Solutions, Instem

Dr. Arianna Bassan

Principal Consultant at Innovatune

Dr. Frances Hall

Senior Director, In Silico Solutions, Instem